Article: CHINA BIOPHARMACEUTICALS' GROSS PROFIT INCREASES 102%.

China Biopharmaceuticals Holdings, Inc. (BULLETIN BOARD: CHBP) , a leading Chinese pharmaceutical company focused on the development, manufacturing and marketing of innovative drugs in China, has announced its results for the third quarter ended September 30, 2007.

Revenue for the three months ended September 30, 2007 increased 65% to $8.6 million compared to $5.2 million for the period ended September 30, 2006. The increase in revenues was attributable to the revenue growth of the company's subsidiary Eyre Pharmaceutical Limited Company (''Erye''). Additionally, the company did not realize quarterly revenue from Shenyang Enshi Pharmaceutical Limited Company ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!